Transaction · 0001193125-26-388297

Ladone Mary Kay

Ladone Mary Kay, DIR, reported an open-market or private sale at KESTRA MEDICAL TECHNOLOGIES, LTD. involving 3908.000000 shares for an estimated $98464.40. Reported holdings after the transaction were 37507.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SDIR
KMTSKESTRA MEDICAL TECHNOLOGIES, LTD.
Disclosed value-$98.4kShares × reported price
Shares traded3.90k$25.20 per share
Holdings after37.5kDirect
% of reported position traded9.44%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 41,415 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

KMTS price since this filing

Daily closing prices, with the filing date and available return windows
KMTS · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +15.5%1w ago +9.9%1d ago +11.8%
Returns since7d +6.9%30d +18.1%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001193125-26-388297
Common Shares
Transaction date
Sep 08, 2026
Filed Sep 11, 2026, 12:25 AM · 3d delay
Shares
3,908 sh
$25.20 per share
Estimated value
-$98.4k
Computed from shares × price
Holdings after
37,507 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership
Filing-only score

+6 points

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations…

  2. F2

    The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $24.9100 to $25.4300. Upon request, the reporting person will provide to the Issuer…

  3. F3

    Includes 17,512 Common Shares received from West Affum Holdings, L.P., in a pro rata distribution exempt pursuant to Rule 16a-9.

  4. F4

    The reported securities represent restricted stock units which each entitle the reporting person to receive one common share of the Issuer. The restricted stock units will vest on September 9, 2027, s…

Original filing · 0001193125-26-388297
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

KMTS